3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioma
3
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Ependymoma
2
Cholangiocarcinoma
2
Xanthogranuloma, Juvenile
1
Neoplasms, Unknown Primary
1
Histiocytic Sarcoma
1
Central Nervous System Neoplasms
1
Interventions
Gemcitabine
18
Cisplatin
12
Oxaliplatin
7
pembrolizumab
6
Nivolumab
6
Capecitabine
4
trametinib
3
Fluorouracil
3
Bevacizumab
3
tremelimumab
2
lenvatinib
2
durvalumab
2
derazantinib
2
atezolizumab
2
Trastuzumab
2
Ramucirumab
2
Radiofrequency Ablation
2
Panitumumab
2
Leucovorin
2
Cryosurgery
2
zanidatamab
1
vandetanib
1
tucatinib
1
tocilizumab
1
telotristat ethyl
1
sargramostim
1
rucaparib
1
regorafenib
1
pertuzumab
1
milademetan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Biliary Tract Neoplasms
×
ivosidenib
×
Clear all
No trials found.